Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
GLUE
Stock Latest News
The Fly
Monte Rosa Therapeutics assumed with a Buy at UBS
10d ago
GLUE
Premium
Company Announcements
Monte Rosa Reports Positive Phase 1 Data for MRT-8102
21d ago
8K
GLUE
Premium
The Fly
Monte Rosa announces data from GFORCE-1, plans for Phase 2 program of MRT-8102
21d ago
GLUE
Premium
The Fly
Monte Rosa Therapeutics initiated with a Buy at H.C. Wainwright
21d ago
GLUE
Premium
The Fly
Closing Bell Movers: Micron little changed after earnings
21d ago
MU
NU
Premium
The Fly
Monte Rosa Therapeutics to present results of MRT-8102 GFORCE-1 Phase 1 study
21d ago
GLUE
Premium
Ratings
Novartis-Backed MRT-6160 Expansion and Strong Partnership Economics Underpin Oliver McCammon’s Buy Rating on Monte Rosa’s GLUE
1M ago
GLUE
Premium
Company Announcements
Monte Rosa earns milestone as MRT-6160 enters Phase 2
1M ago
8K
GLUE
Premium
The Fly
Monte Rosa Therapeutics to receive $50M milestone payment from Novartis
1M ago
NVS
GLUE
Premium
The Fly
Monte Rosa Therapeutics doses first patient in MODeFIRe-1 trial
2M ago
GLUE
Premium
The Fly
Monte Rosa Therapeutics price target lowered to $28 from $35 at Guggenheim
3M ago
GLUE
Premium
Ratings
Analyst Maintains Buy on Monte Rosa, Citing Differentiated Degrader Platform, Strategic Partnerships, and Cash Runway as Share Weakness Creates Entry Point
3M ago
GLUE
Premium
The Fly
Monte Rosa Therapeutics reports Q2 revenue $8.97M, consensus $12.88M
3M ago
GLUE
Premium
Company Announcements
Monte Rosa’s MODeFIRe-1 Trial Pushes GLUE Into a Key Mid-Stage Prostate Cancer Test
3M ago
GLUE
Premium
The Fly
Monte Rosa Therapeutics price target lowered to $27 from $37 at Wedbush
3M ago
NVO
GLUE
Premium
The Fly
Monte Rosa, BioAge sink following Novo Nordisk’s ZEUS setback
3M ago
NVO
BIOA
Premium
Ratings
Buy Rating Maintained on Monte Rosa as Diversified Degrader Pipeline and Novartis Partnership Offset ZEUS Cardiovascular Setback
3M ago
GLUE
Premium
The Fly
Monte Rosa Therapeutics price target lowered at Jefferies after Novo trial miss
3M ago
NVO
GLUE
Premium
The Fly
Monte Rosa Therapeutics price target raised to $40 from $30 at Jefferies
3M ago
NVO
GLUE
Premium
The Fly
Monte Rosa Therapeutics price target raised, named a ‘top pick’ at Guggenheim
4M ago
GLUE
Premium
The Fly
Monte Rosa Therapeutics price target raised to $31 from $30 at JPMorgan
5M ago
GLUE
Premium
The Fly
Monte Rosa Therapeutics reports Q1 revenue $4.21M, consensus $11.39M
6M ago
GLUE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
